JMA to Call on PAFSC Committee to Review Once Again Switch-OTC of Epadel

Toshio Nakagawa, Vice President, Japan Medical Association Regarding the switch-OTC version of the ethical dyslipidemia treatment Epadel (ehyl icosapentate), the Japan Medical Association (JMA) on November 21 released its view expressing its opposition against a switch-OTC for the treatment of...read more